Search

Your search keyword '"Koga, Fumitaka"' showing total 992 results
Start Over Author "Koga, Fumitaka"
992 results on '"Koga, Fumitaka"'

1. Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group)

Author

Yokoyama, Yuki, Kawase, Makoto, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, and Koie, Takuya

Published
2024
Full Text
View/download PDF

2. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)

Author

Sasaki, Takeshi, Ebara, Shin, Tatenuma, Tomoyuki, Ikehata, Yoshinori, Nakayama, Akinori, Kawase, Makoto, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Kitamura, Hiroshi, Saito, Kazutaka, Koie, Takuya, Koga, Fumitaka, Urakami, Shinji, and Inoue, Takahiro

Published
2024
Full Text
View/download PDF

3. Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)

Author

Toide, Masahiro, Ebara, Shin, Tatenuma, Tomoyuki, Ikehata, Yoshinori, Nakayama, Akinori, Kawase, Makoto, Sasaki, Takeshi, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Kitamura, Hiroshi, Saito, Kazutaka, Koie, Takuya, Inoue, Takahiro, Urakami, Shinji, and Koga, Fumitaka

Published
2024
Full Text
View/download PDF

4. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group)

Author

Kawase, Makoto, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, and Koie, Takuya

Published
2024
Full Text
View/download PDF

6. Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)

Author

Kawase, Makoto, Goto, Takayuki, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ishihara, Takuma, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Kobayashi, Takashi, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, and Koie, Takuya

Published
2023
Full Text
View/download PDF

8. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

Author

Yoshida, Soichiro, Takahara, Taro, Arita, Yuki, Ito, Masaya, Hayakawa, Sara, Oguchi, Tomohiko, Komai, Yoshinobu, Numao, Noboru, Yuasa, Takeshi, Inoue, Masaharu, Ushijima, Hiroki, Kudo, Shigehiro, Shimano, Yasumasa, Nakamura, Yuki, Uchida, Yusuke, Uehara, Sho, Tanaka, Hajime, Yaegashi, Hiroshi, Izumi, Kouji, Yokoyama, Minato, Matsuoka, Yoh, Yoshioka, Yasuo, Konishi, Koji, Nakanishi, Katsuyuki, Nagahara, Akira, Hirakawa, Akihiro, Koike, Ryuji, Koga, Fumitaka, Nishimura, Kazuo, Mizokami, Atsushi, Yonese, Junji, Kageyama, Yukio, Yoshimura, Ryoichi, and Fujii, Yasuhisa

Published
2023
Full Text
View/download PDF

9. Association of hospital volume with perioperative and oncological outcomes of robot-assisted laparoscopic radical prostatectomy: a retrospective multicenter cohort study

Author

Tatenuma, Tomoyuki, Ebara, Shin, Kawase, Makoto, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, Koie, Takuya, and Makiyama, Kazuhide

Published
2023
Full Text
View/download PDF

10. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)

Author

Kawase, Makoto, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, and Koie, Takuya

Published
2023
Full Text
View/download PDF

12. ASO Visual Abstract: Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy—A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group)

Author

Kawase, Makoto, Goto, Takayuki, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ishihara, Takuma, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Kobayashi, Takashi, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, and Koie, Takuya

Published
2023
Full Text
View/download PDF

14. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)

Author

Sugino, Yusuke, Sasaki, Takeshi, Ebara, Shin, Tatenuma, Tomoyuki, Ikehata, Yoshinori, Nakayama, Akinori, Kawase, Makoto, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Kitamura, Hiroshi, Saito, Kazutaka, Koie, Takuya, Koga, Fumitaka, Urakami, Shinji, and Inoue, Takahiro

Published
2022
Full Text
View/download PDF

16. Twisting of Inflatable Penile Prosthesis Tubing Leading to Device Malfunction and Required Explantation: A Rare Complication.

Author

Sarver, Jordan, Emmer, Eriel, Benben, Alex, Skalak, Matthew, Talley, Daniel, Abdelhady, Mazen, and Koga, Fumitaka

Subjects
PENILE prostheses, PATIENT satisfaction, MECHANICAL failures, SEXUAL intercourse, CONSERVATIVE treatment
Abstract

Erectile dysfunction (ED), the impairment of achieving and maintaining an erection for satisfactory sexual intercourse, is a common pathology that men experience for a variety of different factors. Conservative treatment for ED includes changing medications, lifestyle modifications, and psychotherapy. Pharmaceutical and nonsurgical interventions include phosphodiesterase‐5 inhibitors(PDE‐5i), intracavernosal medication injections, and vacuum devices. Surgical treatment options for ED have evolved over time and currently include the use of inflatable penile prosthesis (IPP) and malleable penile prosthesis. IPP insertion is usually met with good patient satisfaction. However, complications of device insertion can include corporal perforation, urethral injury, cylinder erosion or extrusion, infection, and mechanical failure, to name a few. Our patient presented with device malfunction and intraoperative assessment showed the IPP tubing twisted at the levels of the reservoir on the first operation and the level of the cylinder and scrotal pump on the second operation. The twisting of the tubing resulted in a nonfunctioning IPP as the fluid was unable to fill the cylinders resulting in an erection. The patient was managed with complete device explanation and reinsertion of a new three‐piece IPP per the patient and partner's request. This is the first case report highlighting this specific complication, and we hope to provide clinicians with the resources to recognize this rare complication. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. KL‐6 Mucin as Serum Tumor Marker of Metastatic Renal Cancer: A Case Report.

Author

Ishida, Kyohei, Hasegawa, Go, Takada, Toshinori, Ogose, Akira, Kawaguchi, Gen, Ikeda, Yohei, Nishiyama, Hiroki, Hara, Noboru, Nishiyama, Tsutomu, and Koga, Fumitaka

Subjects
RENAL cancer, TUMOR markers, BIOMARKERS, KIDNEY failure, METASTASIS
Abstract

We encountered a case of metastatic renal cell carcinoma in which the serum level of KL‐6, a therapeutic marker, was exceptionally high and fluctuated with the progression of treatment. A 74‐year‐old man was diagnosed with right renal cystic cancer and multiple metastases in October 2022. The KL‐6 level was 27490 U/mL. He started treatment with lenvatinib and pembrolizumab. KL‐6 decreased to 3885 U/mg in February 2023. The patient's proteinuria worsened, leading to the discontinuation of lenvatinib. KL‐6 increased to 25950 U/mL in April. He discontinued pembrolizumab and started taking cabozantinib. In September, drug‐induced bilateral inflammatory pneumonitis developed. He discontinued cabozantinb and began taking axitinib. KL‐6 decreased; however, he suffered from severe diarrhea and subsequent renal insufficiency. He discontinued axitinib in November. KL‐6 increased to 29640 U/mL in December. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. MP53-06 GUSTAVE ROUSSY IMMUNE SCORE PREDICTS SURVIVAL OUTCOME OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA TREATED WITH PEMBROLIZUMAB: A MULTICENTER STUDY OF 321 PATIENTS (YUSHIMA STUDY)

Author

Tanabe, Kenji, primary, Kobayashi, Shuichiro, additional, Nagahama, Katsushi, additional, Yonese, Junji, additional, Otsuka, Yukihiro, additional, Okuno, Tetsuo, additional, Takazawa, Ryoji, additional, Noro, Akira, additional, Yano, Masataka, additional, Tsukamoto, Tetsuro, additional, Saito, Kazutaka, additional, Sakai, Yasuyuki, additional, Koga, Fumitaka, additional, Kageyama, Yukio, additional, Tanaka, Hajime, additional, Yoshida, Soichiro, additional, and Fujii, Yasuhisa, additional

Published
2024
Full Text
View/download PDF

19. MP53-13 REAL-WORD OUTCOMES OF MAINTENANCE CHEMOTHERAPY VERSUS AVELUMAB THERAPY AFTER FIRST-LINE INDUCTION CHEMOTHERAPY FOR ADVANCED UROTHELIAL CARCINOMA: YUSHIMA STUDY

Author

Izumi, Keita, primary, Tanaka, Hajime, additional, Yano, Masataka, additional, Takazawa, Ryoji, additional, Noro, Akira, additional, Tsukamoto, Tetsuro, additional, Yonese, Junji, additional, Okuno, Tetsuo, additional, Sakai, Yasuyuki, additional, Koga, Fumitaka, additional, Kageyama, Yukio, additional, Saito, Kazutaka, additional, and Fujii, Yasuhisa, additional

Published
2024
Full Text
View/download PDF

20. MP52-04 NOMOGRAM PREDICTING LOCALLY ADVANCED PROSTATE CANCER IN PATIENTS WITH CLINICALLY ORGAN-CONFINED DISEASE WHO UNDERWENT ROBOT-ASSISTED RADICAL PROSTATECTOMY: A RETROSPECTIVE MULTICENTER COHORT STUDY IN JAPAN (THE MSUG94 GROUP)

Author

Kawase, Makoto, primary, Goto, Takayuki, additional, Ebara, Shin, additional, Tatenuma, Tomoyuki, additional, Sasaki, Takeshi, additional, Ishihara, Takuma, additional, Ikehata, Yoshinori, additional, Nakayama, Akinori, additional, Toide, Masahiro, additional, Yoneda, Tatsuaki, additional, Sakaguchi, Kazushige, additional, Teishima, Jun, additional, Kobayashi, Takashi, additional, Makiyama, Kazuhide, additional, Inoue, Takahiro, additional, Kitamura, Hiroshi, additional, Saito, Kazutaka, additional, Koga, Fumitaka, additional, Urakami, Shinji, additional, and Koie, Takuya, additional

Published
2024
Full Text
View/download PDF

21. Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review.

Author

Zarba, Martin, Fujiwara, Ryo, Yuasa, Takeshi, Koga, Fumitaka, Heng, Daniel Y C, and Takemura, Kosuke

Subjects
RENAL cell carcinoma, STEREOTACTIC radiotherapy, METASTASIS, PATIENT selection, METASTASECTOMY, COMBINED modality therapy
Abstract

Systemic and local therapies for patients with metastatic renal cell carcinoma (mRCC) are often challenging despite the evolution of multimodal cancer therapies in the last decade. In this review, we will focus on recent multidisciplinary approaches for patients with mRCC. Systemic therapies for patients with mRCC have been garnering attention particularly after the approval of immuno-oncology (IO) agents, including anti-programmed death 1/programmed death-ligand 1. IO combinations have significantly prolonged overall survival in patients with mRCC in the first-line setting. Regarding local therapies, cytoreductive nephrectomy (CN) has become less common in the post-Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques (CARMENA) trial era, even though CN may still benefit selected patients with mRCC. In addition, metastasis-directed local therapies, namely metastasectomy or stereotactic radiotherapy, particularly for oligo-metastatic lesions or brain metastases, may have a prognostic impact. Several ablative techniques are also evolving while maintaining high local control rates with acceptable safety. Multimodal cancer therapies are essential for conquering complex cases of mRCC. Modern systemic therapies including IO-based combination therapy as well as local therapies including CN, metastasectomy, stereotactic radiotherapy, and ablative techniques appear to improve oncologic outcomes of patients with mRCC, although appropriate patient selection is indispensable. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. Early and late urinary continence outcomes after unilateral and bilateral nerve‐sparing robot‐assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group)

Author

Sakaguchi, Kazushige, primary, Ebara, Shin, additional, Tatenuma, Tomoyuki, additional, Sasaki, Takeshi, additional, Ikehata, Yoshinori, additional, Nakayama, Akinori, additional, Kawase, Makoto, additional, Toide, Masahiro, additional, Yoneda, Tatsuaki, additional, Teishima, Jun, additional, Makiyama, Kazuhide, additional, Inoue, Takahiro, additional, Kitamura, Hiroshi, additional, Saito, Kazutaka, additional, Koie, Takuya, additional, Koga, Fumitaka, additional, and Urakami, Shinji, additional

Published
2023
Full Text
View/download PDF

29. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.

Author

Yoshida, Soichiro, Tsutsumi, Shinji, Muhlebach, Guillaume, Sourbier, Carole, Lee, Min-Jung, Lee, Sunmin, Vartholomaiou, Evangelia, Tatokoro, Manabu, Beebe, Kristin, Miyajima, Naoto, Mohney, Robert, Chen, Yang, Hasumi, Hisashi, Xu, Wanping, Fukushima, Hiroshi, Koga, Fumitaka, Kihara, Kazunori, Trepel, Jane, Picard, Didier, Neckers, Leonard, and Nakamura, Ken

Subjects
Animals, COS Cells, CSK Tyrosine-Protein Kinase, Chlorocebus aethiops, Glycolysis, HSP90 Heat-Shock Proteins, HeLa Cells, Humans, Intracellular Signaling Peptides and Proteins, Mice, Mice, Knockout, Mitochondria, Mitochondrial Proteins, Molecular Chaperones, NIH 3T3 Cells, Neoplasm Invasiveness, Oxidative Phosphorylation, RNA Interference, Transfection, src-Family Kinases
Abstract

TRAP1 (TNF receptor-associated protein), a member of the HSP90 chaperone family, is found predominantly in mitochondria. TRAP1 is broadly considered to be an anticancer molecular target. However, current inhibitors cannot distinguish between HSP90 and TRAP1, making their utility as probes of TRAP1-specific function questionable. Some cancers express less TRAP1 than do their normal tissue counterparts, suggesting that TRAP1 function in mitochondria of normal and transformed cells is more complex than previously appreciated. We have used TRAP1-null cells and transient TRAP1 silencing/overexpression to show that TRAP1 regulates a metabolic switch between oxidative phosphorylation and aerobic glycolysis in immortalized mouse fibroblasts and in human tumor cells. TRAP1-deficiency promotes an increase in mitochondrial respiration and fatty acid oxidation, and in cellular accumulation of tricarboxylic acid cycle intermediates, ATP and reactive oxygen species. At the same time, glucose metabolism is suppressed. TRAP1-deficient cells also display strikingly enhanced invasiveness. TRAP1 interaction with and regulation of mitochondrial c-Src provide a mechanistic basis for these phenotypes. Taken together with the observation that TRAP1 expression is inversely correlated with tumor grade in several cancers, these data suggest that, in some settings, this mitochondrial molecular chaperone may act as a tumor suppressor.

Published
2013

33. Early and late urinary continence outcomes after unilateral and bilateral nerve‐sparing robot‐assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group).

Author

Sakaguchi, Kazushige, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Kawase, Makoto, Toide, Masahiro, Yoneda, Tatsuaki, Teishima, Jun, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koie, Takuya, Koga, Fumitaka, and Urakami, Shinji

Published
2024
Full Text
View/download PDF

34. The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group).

Author

Murase, Kazumasa, Kawase, Makoto, Ebara, Shin, Tatenuma, Tomoyuki, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Makiyama, Kazuhide, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, and Koie, Takuya

Subjects
RADICAL prostatectomy, SURGICAL robots, PROSTATE cancer, PROSTATE cancer patients, RECEIVER operating characteristic curves
Abstract

Background and Objectives: We aimed to examine the relationship between the inflammation-related parameters, such as the neutrophil-to-lymphocyte ratio (NLR), and the pathological findings and biochemical recurrence (BCR) in patients with prostate cancer (PCa) undergoing robot-assisted radical prostatectomy (RARP). Materials and Methods: A retrospective multicenter cohort study of patients with PCa who underwent RARP at 10 institutes in Japan was conducted. This study enrolled 3195 patients. We focused on patients undergoing RARP who underwent the preoperative measurement of their inflammation-related parameters and who did not receive any neo- or adjuvant therapy. Data on the pre- and postoperative variables for the enrolled patients were obtained. The primary endpoint of this study was the association between BCR and the inflammation-related parameters after RARP. The secondary endpoint was the association between the inflammation-related parameters and the pathological diagnosis of PCa. Results: Data from 2429 patients with PCa who met the study's eligibility criteria were analyzed. The median follow-up period was 25.1 months. The inflammation-related parameters were divided into two groups, and cutoff values were determined based on the receiver operating characteristics. There were no statistically significant differences in biochemical recurrence-free survival for any of the parameters. In the univariate analysis, the NLR was predictive of pathological T3 and lymphovascular invasion; however, there were no significant differences in the multivariate analysis. Conclusions: The inflammation-related parameters did not significantly affect the incidence of BCR, at least among patients with PCa who underwent RARP. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

42. Ureteral Involvement Is Associated with Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma Patients Treated by Nephroureterectomy: A Multicenter Database Study

Author

Waseda, Yuma, Saito, Kazutaka, Ishioka, Junichiro, Matsuoka, Yoh, Numao, Noboru, Fujii, Yasuhisa, Sakai, Yasuyuki, Koga, Fumitaka, Okuno, Tetsuo, Arisawa, Chizuru, Kamata, Shigeyoshi, Nagahama, Katsuji, Masuda, Hitoshi, Yonese, Junji, Kageyama, Yukio, Noro, Akira, Tsujii, Toshihiko, Morimoto, Shinji, Gotoh, Shuichi, and Kihara, Kazunori

Published
2016
Full Text
View/download PDF

44. Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group)

Author

Sasaki, Takeshi, primary, Ebara, Shin, additional, Tatenuma, Tomoyuki, additional, Ikehata, Yoshinori, additional, Nakayama, Akinori, additional, Kawase, Makoto, additional, Toide, Masahiro, additional, Yoneda, Tatsuaki, additional, Sakaguchi, Kazushige, additional, Teishima, Jun, additional, Makiyama, Kazuhide, additional, Kitamura, Hiroshi, additional, Saito, Kazutaka, additional, Koie, Takuya, additional, Koga, Fumitaka, additional, Urakami, Shinji, additional, and Inoue, Takahiro, additional

Published
2023
Full Text
View/download PDF

47. Additional file 1 of Association of hospital volume with perioperative and oncological outcomes of robot-assisted laparoscopic radical prostatectomy: a retrospective multicenter cohort study

Author

Tatenuma, Tomoyuki, Ebara, Shin, Kawase, Makoto, Sasaki, Takeshi, Ikehata, Yoshinori, Nakayama, Akinori, Toide, Masahiro, Yoneda, Tatsuaki, Sakaguchi, Kazushige, Teishima, Jun, Inoue, Takahiro, Kitamura, Hiroshi, Saito, Kazutaka, Koga, Fumitaka, Urakami, Shinji, Koie, Takuya, and Makiyama, Kazuhide

Abstract

Additional file 1.

Published
2023
Full Text
View/download PDF

48. Additional file 3 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

Author

Yoshida, Soichiro, Takahara, Taro, Arita, Yuki, Ito, Masaya, Hayakawa, Sara, Oguchi, Tomohiko, Komai, Yoshinobu, Numao, Noboru, Yuasa, Takeshi, Inoue, Masaharu, Ushijima, Hiroki, Kudo, Shigehiro, Shimano, Yasumasa, Nakamura, Yuki, Uchida, Yusuke, Uehara, Sho, Tanaka, Hajime, Yaegashi, Hiroshi, Izumi, Kouji, Yokoyama, Minato, Matsuoka, Yoh, Yoshioka, Yasuo, Konishi, Koji, Nakanishi, Katsuyuki, Nagahara, Akira, Hirakawa, Akihiro, Koike, Ryuji, Koga, Fumitaka, Nishimura, Kazuo, Mizokami, Atsushi, Yonese, Junji, Kageyama, Yukio, Yoshimura, Ryoichi, and Fujii, Yasuhisa

Abstract

Additional file 3: The consent form given to participants.

Published
2023
Full Text
View/download PDF

49. Additional file 2 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

Author

Yoshida, Soichiro, Takahara, Taro, Arita, Yuki, Ito, Masaya, Hayakawa, Sara, Oguchi, Tomohiko, Komai, Yoshinobu, Numao, Noboru, Yuasa, Takeshi, Inoue, Masaharu, Ushijima, Hiroki, Kudo, Shigehiro, Shimano, Yasumasa, Nakamura, Yuki, Uchida, Yusuke, Uehara, Sho, Tanaka, Hajime, Yaegashi, Hiroshi, Izumi, Kouji, Yokoyama, Minato, Matsuoka, Yoh, Yoshioka, Yasuo, Konishi, Koji, Nakanishi, Katsuyuki, Nagahara, Akira, Hirakawa, Akihiro, Koike, Ryuji, Koga, Fumitaka, Nishimura, Kazuo, Mizokami, Atsushi, Yonese, Junji, Kageyama, Yukio, Yoshimura, Ryoichi, and Fujii, Yasuhisa

Abstract

Additional file 2: The explanatory document translated to English (the original document is written in Japanese).

Published
2023
Full Text
View/download PDF

50. Additional file 1 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

Author

Yoshida, Soichiro, Takahara, Taro, Arita, Yuki, Ito, Masaya, Hayakawa, Sara, Oguchi, Tomohiko, Komai, Yoshinobu, Numao, Noboru, Yuasa, Takeshi, Inoue, Masaharu, Ushijima, Hiroki, Kudo, Shigehiro, Shimano, Yasumasa, Nakamura, Yuki, Uchida, Yusuke, Uehara, Sho, Tanaka, Hajime, Yaegashi, Hiroshi, Izumi, Kouji, Yokoyama, Minato, Matsuoka, Yoh, Yoshioka, Yasuo, Konishi, Koji, Nakanishi, Katsuyuki, Nagahara, Akira, Hirakawa, Akihiro, Koike, Ryuji, Koga, Fumitaka, Nishimura, Kazuo, Mizokami, Atsushi, Yonese, Junji, Kageyama, Yukio, Yoshimura, Ryoichi, and Fujii, Yasuhisa

Abstract

Additional file 1: SPIRIT 2013 Checklist for the MEDAL trial.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results